{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:21:31Z","timestamp":1761312091106,"version":"3.44.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00210-025-03852-2","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:18:25Z","timestamp":1738732705000},"page":"7713-7720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The efficacy and safety of current treatment of vulvovaginal candidiasis: An umbrella review of systematic reviews and meta-analyses"],"prefix":"10.1007","volume":"398","author":[{"given":"Nasser","family":"Keikha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahman","family":"Fouladi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hossein","family":"Yadegari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"issue":"3","key":"3852_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1179\/joc.2009.21.3.243","volume":"21","author":"C Abad","year":"2009","unstructured":"Abad C, Safdar N (2009) The role of lactobacillus probiotics in the treatment or prevention of urogenital infections\u2013a systematic review. J Chemother 21(3):243\u201352","journal-title":"J Chemother"},{"key":"3852_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","volume":"45","author":"R Bellmann","year":"2017","unstructured":"Bellmann R, Smuszkiewicz P (2017) Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection. 45:737\u201379","journal-title":"Infection."},{"issue":"3","key":"3852_CR3","doi-asserted-by":"publisher","first-page":"101138","DOI":"10.1016\/j.mycmed.2021.101138","volume":"31","author":"RA Bender","year":"2021","unstructured":"Bender RA, \u00c7al\u0131\u015fkan \u015e, \u00d6nal B, Aslancan R, \u00c7al\u0131\u015fkan E (2021) Treatment methods for vulvovaginal candidiasis in pregnancy. J Med Mycol 31(3):101138","journal-title":"J Med Mycol"},{"key":"3852_CR4","first-page":"106","volume":"25","author":"S Boussios","year":"2012","unstructured":"Boussios S, Pentheroudakis G, Katsanos K, Pavlidis N (2012) Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management. Annals Gastroenterol 25:106\u2013118","journal-title":"Annals Gastroenterol"},{"issue":"1","key":"3852_CR5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1186\/s12879-022-07619-5","volume":"22","author":"EE Dovo","year":"2022","unstructured":"Dovo EE, Zohoncon TM, Tovo SF, Soubeiga ST, Kiendrebeogo IT, Yonli AT et al (2022) First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou\/Burkina Faso. BMC Infect Dis 22(1):678","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3852_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/birt.12526","volume":"48","author":"P Foessleitner","year":"2021","unstructured":"Foessleitner P, Petricevic L, Boerger I, Steiner I, Kiss H, Rieger A et al (2021) HIV infection as a risk factor for vaginal dysbiosis, bacterial vaginosis, and candidosis in pregnancy: a matched case-control study. Birth 48(1):139\u201346","journal-title":"Birth"},{"issue":"1","key":"3852_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.30699\/jogcr.5.1.11","volume":"5","author":"B Fouladi","year":"2020","unstructured":"Fouladi B, Rezaei Keikhaie K, Rajabpoor Nikoo N, Amini Poya S, Saravani S, Farzi J (2020) Phenotypic evaluation of strains of Candida albicans and non-albicans Candida species in patients with vulvovaginal candidiasis visiting Amir-al-momenin Hospital in Zabol, Iran in 2019. J Obstetr Gynecol Cancer Res 5(1):11\u20138","journal-title":"J Obstetr Gynecol Cancer Res"},{"issue":"4","key":"3852_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1128\/CMR.12.4.501","volume":"12","author":"MA Ghannoum","year":"1999","unstructured":"Ghannoum MA, Rice LB (1999) Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12(4):501\u201317","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"3852_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1079\/BJN20051428","volume":"93","author":"F Guarner","year":"2005","unstructured":"Guarner F, Perdigon G, Corthier G, Salminen S, Koletzko B, Morelli L (2005) Should yoghurt cultures be considered probiotic? Br J Nutr 93(6):783\u20136","journal-title":"Br J Nutr"},{"key":"3852_CR10","unstructured":"Jeanmonod R JD. Vaginal candidiasis 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459317\/"},{"issue":"4","key":"3852_CR11","first-page":"3749","volume":"20","author":"HS Jeng","year":"2020","unstructured":"Jeng HS, Yan TR, Chen JY (2020) Treating vaginitis with probiotics in non-pregnant females: a systematic review and meta-analysis. Exp Ther Med. 20(4):3749\u201365","journal-title":"Exp Ther Med."},{"issue":"4","key":"3852_CR12","first-page":"3749","volume":"20","author":"HS Jeng","year":"2020","unstructured":"Jeng HS, Yan TR, Chen JY (2020) Treating vaginitis with probiotics in non-pregnant females: a systematic review and meta-analysis. Exp Ther Med 20(4):3749\u201365","journal-title":"Exp Ther Med"},{"issue":"1","key":"3852_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18502\/cmm.4.1.26","volume":"4","author":"N Keikha","year":"2018","unstructured":"Keikha N, Shafaghat M, Mousavia SM, Moudi M, Keshavarzi F (2018) Antifungal effects of ethanolic and aqueous extracts of Vitex agnus-castus against vaginal isolates of Candida albicans. Curr Med Mycol 4(1):1","journal-title":"Curr Med Mycol"},{"key":"3852_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.meegid.2019.02.015","volume":"70","author":"N Keikha","year":"2019","unstructured":"Keikha N, Yadegari MH, Rajabibazl M, Amani J, Hosseinzadeh S (2019) The effect of released new synthetic peptide from nanofibrous scaffold of peptide\/poly (vinyl alcohol)\/poly L-lactic acid on expression of secretory aspartyl proteinases 4 to 6 genes of Candida albicans. Infect Gen Evol 70:36\u201341","journal-title":"Infect Gen Evol"},{"key":"3852_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/6746989","volume":"2017","author":"S Khoza","year":"2017","unstructured":"Khoza S, Moyo I, Ncube D (2017) Comparative hepatotoxicity of fluconazole, ketoconazole, itraconazole, terbinafine, and griseofulvin in rats. J Toxicol 2017:1\u20139","journal-title":"J Toxicol"},{"issue":"4","key":"3852_CR16","first-page":"487","volume":"42","author":"D Lijuan","year":"2022","unstructured":"Lijuan D, Lu Y, Liping W, Yaya S, Xiaoyun L, Xiangrong L (2022) Effectiveness of redcore lotion in patients with vulvovaginal candidiasis: a systematic review and Meta-analysis. J Trad Chin Med 42(4):487","journal-title":"J Trad Chin Med"},{"issue":"4","key":"3852_CR17","first-page":"487","volume":"42","author":"D Lijuan","year":"2022","unstructured":"Lijuan D, Lu Y, Liping W, Yaya S, Xiaoyun L, Xiangrong LI (2022) Effectiveness of redcore lotion in patients with vulvovaginal candidiasis: a systematic review and Meta-analysis. J Tradit Chin Med. 42(4):487\u201392","journal-title":"J Tradit Chin Med."},{"issue":"5","key":"3852_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027489","volume":"9","author":"J L\u00edrio","year":"2019","unstructured":"L\u00edrio J, Giraldo PC, Amaral RL, Sarmento ACA, Costa APF, Gon\u00e7alves AK (2019) Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol. BMJ Open. 9(5):e027489","journal-title":"BMJ Open."},{"issue":"Suppl 4","key":"3852_CR19","first-page":"3","volume":"70","author":"RS Morton","year":"1977","unstructured":"Morton RS, Rashid S (1977) Candidal vaginitis: natural history, predisposing factors and prevention. Proc R Soc Med. 70(Suppl 4):3\u20136","journal-title":"Proc R Soc Med."},{"key":"3852_CR20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372:n71","journal-title":"BMJ."},{"issue":"1","key":"3852_CR21","first-page":"38","volume":"3","author":"NA Phillips","year":"2022","unstructured":"Phillips NA, Bachmann G, Haefner H, Martens M, Stockdale C (2022) Topical treatment of recurrent vulvovaginal candidiasis: an expert consensus. Womens Health Rep (New Rochelle). 3(1):38\u201342","journal-title":"Womens Health Rep (New Rochelle)."},{"key":"3852_CR22","unstructured":"Prevention CfDCa (2022)\u00a0Vulvovaginal candidiasis (VVC). Available from: https:\/\/www.cdc.gov\/std\/treatment-guidelines\/candidiasis.htm#:~:text=VVC%20occurs%20frequently%20during%20pregnancy,for%20use%20among%20pregnant%20women. Accessed 22 July 2021"},{"key":"3852_CR23","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.2147\/IDR.S175588","volume":"11","author":"F Qin","year":"2018","unstructured":"Qin F, Wang Q, Zhang C, Fang C, Zhang L, Chen H et al (2018) Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis. Infect Drug Resist 11:1893","journal-title":"Infect Drug Resist"},{"issue":"2","key":"3852_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejogrb.2012.12.001","volume":"167","author":"MI Rosa","year":"2013","unstructured":"Rosa MI, Silva BR, Pires PS, Silva FR, Silva NC, Silva FR et al (2013) Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 167(2):132\u20136","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"5","key":"3852_CR25","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/AAC.29.5.858","volume":"29","author":"N Ryder","year":"1986","unstructured":"Ryder N, Frank I, Dupont M (1986) Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate. Antimicro Agents Chemother 29(5):858\u201360","journal-title":"Antimicro Agents Chemother"},{"key":"3852_CR26","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J et al (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 358:j4008","journal-title":"BMJ."},{"issue":"5","key":"3852_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2217\/fmb.11.36","volume":"6","author":"RR Spurbeck","year":"2011","unstructured":"Spurbeck RR, Arvidson CG (2011) Lactobacilli at the front line of defense against vaginally acquired infections. Fut Microbiol 6(5):567\u201382","journal-title":"Fut Microbiol"},{"issue":"4","key":"3852_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/jof6040267","volume":"6","author":"V Sustr","year":"2020","unstructured":"Sustr V, Foessleitner P, Kiss H, Farr A (2020) Vulvovaginal candidosis: current concepts, challenges and perspectives. J Fungi (Basel). 6(4):267","journal-title":"J Fungi (Basel)."},{"issue":"2","key":"3852_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrurol.2014.361","volume":"12","author":"SA Whiteside","year":"2015","unstructured":"Whiteside SA, Razvi H, Dave S, Reid G, Burton JP (2015) The microbiome of the urinary tract\u2014a role beyond infection. Nat Rev Urol 12(2):81\u201390","journal-title":"Nat Rev Urol"},{"issue":"1","key":"3852_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/jof6010027","volume":"6","author":"HM Willems","year":"2020","unstructured":"Willems HM, Ahmed SS, Liu J, Xu Z, Peters BM (2020) Vulvovaginal candidiasis: a current understanding and burning questions. J Fungi 6(1):27","journal-title":"J Fungi"},{"key":"3852_CR31","first-page":"1","volume":"2018","author":"X Zeng","year":"2018","unstructured":"Zeng X, Zhang Y, Zhang T, Xue Y, Xu H, An R (2018) Risk factors of vulvovaginal candidiasis among women of reproductive age in Xi\u2019an: a cross-sectional study. BioMed Res Int 2018:1\u20138","journal-title":"BioMed Res Int"},{"key":"3852_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0754-2","volume":"7","author":"Y Zhai","year":"2019","unstructured":"Zhai Y, Ye X, Hu F, Xu J, Guo X, Zhuang Y et al (2019) Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system. J Immunother Cancer. 7:1\u201311","journal-title":"J Immunother Cancer."},{"issue":"13","key":"3852_CR33","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/1471-0528.15913","volume":"126","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang X, Zhou YY, Jiang CM, Jiang HY (2019) The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis. Bjog. 126(13):1546\u201352","journal-title":"Bjog."}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03852-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-03852-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03852-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T04:38:53Z","timestamp":1757133533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-03852-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["3852"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-03852-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}